STVN Stevanato Group S.p.A.

NYSE
$21.06

Stevanato Group S.p.A. (STVN) is expected to report earnings on November 3, 2026, before the market open. The consensus earnings estimate is $0.17 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.8% since its last earnings release on August 4, 2026.

Stevanato Group S.p.A. Beat Consensus Estimates
Tuesday, August 4, 2026 · 6:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 3
Tuesday · 6:30 AM ET
Earnings Whisper
-
vs $0.17
Rev est $371.52M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $20.58

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Stevanato Group S.p.A.

Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries.

Sector

Healthcare

Industry

Medical Instruments/Supply